Vascularized Cardiac Spheroids as Novel 3D in vitro Models to Study Cardiac Fibrosis
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Spheroid cultures are among the most explored cellular biomaterials used in cardiovascular research, due to their improved integration of biochemical and physiological features of the heart in a defined architectural three-dimensional microenvironment when compared to monolayer cultures. To further explore the potential use of spheroid cultures for research, we engineered a novel in vitro model of the heart with vascularized cardiac spheroids (VCSs), by coculturing cardiac myocytes, endothelial cells, and fibroblasts isolated from dissociated rat neonatal hearts (aged 1-3 days) in hanging drop cultures. To evaluate the validity of VCSs in recapitulating pathophysiological processes typical of the in vivo heart, such as cardiac fibrosis, we then treated VCSs with transforming growth factor beta 1 (TGFβ1), a known profibrotic agent. Our mRNA analysis demonstrated that TGFβ1-treated VCSs present elevated levels of expression of connective tissue growth factor, fibronectin, and TGFβ1 when compared to control cultures. We demonstrated a dramatic increase in collagen deposition following TGFβ1 treatment in VCSs in the PicroSirius Red-stained sections. Doxorubicin, a renowned cardiotoxic and profibrotic agent, triggered apoptosis and disrupted vascular networks in VCSs. Taken together, our findings demonstrate that VCSs are a valid model for the study of the mechanisms involved in cardiac fibrosis, with the potential to be used to investigate novel mechanisms and therapeutics for treating and preventing cardiac fibrosis in vitro.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In addition, cell death and disturbed vascular networks in spheroids were observed after addition of a cardiotoxic and profibrotic agent (i.e. Doxorubicin).”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [311]
In the citing paper
“These findings demonstrate that cardiac spheroids can be used to elucidate the underlying pathways as well as therapeutics for preventing and treating cardiac fibrosis in vitro [311].”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [311]
In the citing paper
“A significant rise in collagen deposition following TGFβ1 treatment in spheroids was observed.”
From Cardiovascular disease models: A game changing paradigm in drug discovery and screening (2019) · cites this paper as [311]
Citations
Cites
Cardiac Fibrosis: The Fibroblast Awakens
Travers, J. G., Kamal, F. A., Robbins, J., Yutzey, K. E., & Blaxall, B. C. (2016) · Circulation Research · doi:10.1161/circresaha.115.306565 · Cited by 1,596
Revisiting Cardiac Cellular Composition
Pinto, A. R., Ilinykh, A., Ivey, M. J., Kuwabara, J. T., D’Antoni, M. L., Debuque, R., Chandran, A., Wang, L., Arora, K., Rosenthal, N. A., et al. (2016) · Circulation Research · doi:10.1161/circresaha.115.307778 · Cited by 1,400 · cited 13×
“Neonatal rat hearts contain approximately 30% CFs, 64% CMs, and 6% ECs [Banerjee et al., 2007].”
BackgroundInfluentialTransforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934
Structural and functional characterisation of cardiac fibroblasts
CAMELLITI, P., BORG, T., & KOHL, P. (2005) · Cardiovascular Research · doi:10.1016/j.cardiores.2004.08.020 · Cited by 930 · cited 3×
“Interstitial fibroblasts contribute to the biochemical, structural, and electromechanical properties of the myocardium, and are therefore are of particular interest for their major role in the development of cardiac fibrosis following their transdifferentiation into myofibroblasts [Brown et al., 2005; Camelliti et al.…”
BackgroundMethodMyofibroblast-mediated mechanisms of pathological remodelling of the heart
Weber, K. T., Sun, Y., Bhattacharya, S. K., Ahokas, R. A., & Gerling, I. C. (2013) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2012.158 · Cited by 673
Growth of engineered human myocardium with mechanical loading and vascular coculture
Tulloch, N. L., Muskheli, V., Razumova, M. V., Korte, F. S., Regnier, M., Hauch, K. D., Pabon, L., Reinecke, H., & Murry, C. E. (2011) · Circulation Research · doi:10.1161/circresaha.110.237206 · Cited by 666
THE CARDIAC FIBROBLAST: Therapeutic Target in Myocardial Remodeling and Failure
Brown, R. D., Ambler, S. K., Mitchell, M. D., & Long, C. S. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095802 · Cited by 647
Banerjee, I., Fuseler, J. W., Price, R. L., Borg, T. K., & Baudino, T. A. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00514.2007 · Cited by 629 · cited 5×
“Neonatal rat hearts contain approximately 30% CFs, 64% CMs, and 6% ECs [Banerjee et al., 2007].”
BackgroundMethodInfluentialTissue engineering of vascularized cardiac muscle from human embryonic stem cells
Caspi, O., Lesman, A., Basevitch, Y., Gepstein, A., Arbel, G., Habib, I. H. M., Gepstein, L., & Levenberg, S. (2007) · Circulation Research · doi:10.1161/01.res.0000257776.05673.ff · Cited by 558 · cited 1×
“3D in vitro cocultures of isolated CMs, ECs, and CFs from different origin have been explored, using either scaffolds [Caspi et al., 2007, Tulloch et al., 2011] or a scaffold-free technique, such as spheroid cultures for regenerative medicine purposes [Stevens et al., 2009, Noguchi et al., 2016] or…”
MethodWhittaker, P., Kloner, R. A., Boughner, D. R., & Pickering, J. G. (1994) · Basic Research in Cardiology · doi:10.1007/bf00788278 · Cited by 496 · cited 2×
“We also demonstrated how VCSs are good models for the study of other fibrotic stimuli besides TGFβ1, such as DOX (at concentrations within the therapeutic range) [Wilkinson and Mawer, 1974, Eckes et al., 2011] ( Fig.”
BackgroundRedox Signaling in Cardiac Physiology and Pathology
Burgoyne, J. R., Mongue-Din, H., Eaton, P., & Shah, A. M. (2012) · Circulation Research · doi:10.1161/circresaha.111.255216 · Cited by 482 · cited 1×
“The development of cardiac fibrosis involves the recruitment and activation of fibroblasts, stimulated by interactions with CMs, ECs, inflammatory cells, and other circulating cells [Burgoyne et al., 2012].”
BackgroundInduction of Cardiac Fibrosis by Transforming Growth Factor-β1
Lijnen, P. J., Petrov, V. V., & Fagard, R. H. (2000) · Molecular Genetics and Metabolism · doi:10.1006/mgme.2000.3032 · Cited by 464
Stevens, K. R., Kreutziger, K. L., Dupras, S. K., Korte, F. S., Regnier, M., Muskheli, V., Nourse, M. B., Bendixen, K., Reinecke, H., & Murry, C. E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908381106 · Cited by 427
SIRIUS RED F3BA AS A STAIN FOR CONNECTIVE TISSUE.
Sweat, F., Puchtler, H., & Rosenthal, S. I. (1964) · PubMed · Cited by 424
Dobaczewski, M., Bujak, M., Li, N., Gonzalez-Quesada, C., Mendoza, L. H., Wang, X.-F., & Frangogiannis, N. G. (2010) · Circulation Research · doi:10.1161/circresaha.109.216101 · Cited by 385 · cited 2×
“…in VCSs In order to establish the potential of VCSs to undergo fibrosis, we used TGFβ1, which is a key regulator of cardiac fibrosis in vivo and in vitro that is thought to act on ECM remodeling for collagen and fibronectin (FN) via fibroblasts [Bujak et al., 2007, Dobaczewski et al., 2010].”
BackgroundMethodEssential Role of Smad3 in Infarct Healing and in the Pathogenesis of Cardiac Remodeling
Bujak, M., Ren, G., Kweon, H. J., Dobaczewski, M., Reddy, A., Taffet, G., Wang, X.-F., & Frangogiannis, N. G. (2007) · Circulation · doi:10.1161/circulationaha.107.704197 · Cited by 356 · cited 4×
“It plays a well-recognized role in upregulating the drivers of fibrosis that are now used ubiquitously as its molecular markers [Lijnen et al., 2000, Bujak et al., 2007].”
BackgroundMethodInfluentialBeauchamp, P., Moritz, W., Kelm, J. M., Ullrich, N. D., Agarkova, I., Anson, B. D., Suter, T. M., & Zuppinger, C. (2015) · Tissue Engineering Part C: Methods · doi:10.1089/ten.tec.2014.0376 · Cited by 161
Beauchamp, P., Ullrich, N. D., Jens, K., Moritz, W., Agarkova, I. V., Anson, B. D., Suter, T. M., & Zuppinger, C. (2015) · BORIS (University Library Bern) · doi:10.7892/boris.72049 · Cited by 160
The role of mouse strain differences in the susceptibility to fibrosis: a systematic review
Walkin, L., Herrick, S. E., Summers, A., Brenchley, P. E., Hoff, C. M., Korstanje, R., & Margetts, P. J. (2013) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-6-18 · Cited by 160
Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators
Cartledge, J. E., Kane, C., Dias, P., Tesfom, M., Clarke, L., Mckee, B., Al Ayoubi, S., Chester, A., Yacoub, M. H., Camelliti, P., et al. (2015) · Cardiovascular Research · doi:10.1093/cvr/cvu264 · Cited by 158
The role of inflammatory and fibrogenic pathways in heart failure associated with aging
Chen, W., & Frangogiannis, N. G. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9161-y · Cited by 146
Understanding the Impact of 2D and 3D Fibroblast Cultures on In Vitro Breast Cancer Models
Sung, K. E., Su, X., Berthier, E., Pehlke, C., Friedl, A., & Beebe, D. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076373 · Cited by 138 · cited 1×
“3 ) suggest that fewer CFs than ECs are present within VCSs when these are cultured in hanging drops, which is consistent with a reduced proliferation rate for CFs in 3D cultures [Sung et al., 2013].”
BackgroundDesign of Artificial Myocardial Microtissues
Kelm, J. M., Ehler, E., Nielsen, L. K., Schlatter, S., Perriard, J.-C., & Fussenegger, M. (2004) · Tissue Engineering · doi:10.1089/107632704322791853 · Cited by 127
Fusion of uniluminal vascular spheroids: A model for assembly of blood vessels
Fleming, P. A., Argraves, W. S., Gentile, C., Neagu, A., Forgacs, G., & Drake, C. J. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22161 · Cited by 123 · cited 1×
“In our laboratories, we previously generated spheroid cultures of vascular cells with biochemical, morphological, and physiological properties typical of in vivo blood vessels [Gentile et al., 2008; Fleming et al., 2010].”
MethodSelf-citationRavenscroft, S. M., Pointon, A., Williams, A. W., Cross, M. J., & Sidaway, J. E. (2016) · Toxicological Sciences · doi:10.1093/toxsci/kfw069 · Cited by 115
Noguchi, R., Nakayama, K., Itoh, M., Kamohara, K., Furukawa, K., Oyama, J.-I., Node, K., & Morita, S. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.06.001 · Cited by 110 · cited 1×
“…and CFs from different origin have been explored, using either scaffolds [Caspi et al., 2007, Tulloch et al., 2011] or a scaffold-free technique, such as spheroid cultures for regenerative medicine purposes [Stevens et al., 2009, Noguchi et al., 2016] or drug testing [Ravenscroft et al., 2016].”
MethodAldosterone and cardiac fibrosis: in vitro studies
Fullerton, M. J., & Funder, J. W. (1994) · Cardiovascular Research · doi:10.1093/cvr/28.12.1863 · Cited by 106
Npr1-regulated gene pathways contributing to cardiac hypertrophy and fibrosis
Ellmers, L. J., Scott, N. J. A., Piuhola, J., Maeda, N., Smithies, O., Frampton, C. M., Richards, M., & Cameron, V. A. (2007) · Journal of Molecular Endocrinology · doi:10.1677/jme.1.02138 · Cited by 82 · cited 1×
“For instance, VCSs generated using cardiac cells from animals that already present with a severe onset of cardiac fibrosis, such as NPR-1 knockout mice [Ellmers et al., 2007], have the potential to be used to test novel antifibrotic therapeutics in a high-throughput manner.”
BackgroundCrosstalk of cardiomyocytes and fibroblasts in co-cultures
Röther, J., Richter, C., Turco, L., Knoch, F., Mey, I. P., Luther, S., Janshoff, A., Bodenschatz, E., & Tarantola, M. (2015) · Open Biology · doi:10.1098/rsob.150038 · Cited by 60 · cited 1×
“This is critical as the majority of drug-induced cardiomyopathies with consequent cardiac fibrosis are linked to the activation of fibrosis and apoptotic pathways in the heart [Singla, 2015].”
BackgroundCommunication Signals Between Cardiac Fibroblasts and Cardiac Myocytes
Ottaviano, F. G., & Yee, K. O. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e31821209ee · Cited by 55 · cited 2×
“…and cardiomyocytes (CMs) during cardiac fibrosis is responsible for an elevated production of extracellular matrix (ECM) proteins, with the consequent remodeling of cellular and extracellular components, followed by the differentiation of fibroblasts into myofibroblasts [Ottaviano and Yee, 2011].”
BackgroundGarzoni, L. R., Adesse, D., Soares, M. J., Rossi, M. I. D., Borojević, R., & de Meirelles, M. D. N. L. (2008) · The Journal of Infectious Diseases · doi:10.1086/528373 · Cited by 55 · cited 1×
“Spheroids generated from CMs alone have been previously utilized to investigate signaling pathways such as vascular endothelial growth factors [Kelm et al., 2004], contractile activity [Beauchamp et al., 2015], and protozoan-induced cardiac fibrosis [Garzoni et al., 2008].”
MethodZhao, H., Li, X., Zhao, S., Zeng, Y., Zhao, L., Ding, H., Sun, W., & Du, Y. (2014) · Biofabrication · doi:10.1088/1758-5082/6/4/045009 · Cited by 54 · cited 3×
“VCSs as Novel 3D in vitro Models to Study Cardiac Fibrosis Cells Tissues Organs 2017;204:191–198 DOI: 10.1159/000477436 195 DOX Mediates Apoptosis and Remodeling in VCSs DOX, belonging to the family of anthracyclines, has also been linked to cardiac apoptosis and fibrosis [Zhao et al., 2014].”
BackgroundMethodInfluentialSingla, D. K. (2015) · Cell Transplantation · doi:10.3727/096368914x679200 · Cited by 54
Bubb, K. J., Kok, C., Tang, O., Rasko, N. B., Birgisdottir, Å. B., Hansen, T., Ritchie, R. H., Bhindi, R., Reisman, S. A., Meyer, C. J., et al. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.04.027 · Cited by 41
Self-citationVEGF‐mediated fusion in the generation of uniluminal vascular spheroids
Gentile, C., Fleming, P. A., Mironov, V., Argraves, K. M., Argraves, W. S., & Drake, C. J. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21720 · Cited by 39 · cited 4×
“…neonatal rat hearts were first enzymati- cally dissociated, and then cardiac cells were pooled together from different hearts by coculturing them in hanging drops, following an adapted version of our previous protocol for the generation of 3D in vitro vascular spheroids [Gentile et al., 2008].”
MethodResultSelf-citationGentile, C. (2016) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x10666151001114848 · Cited by 36 · cited 13×
“Neonatal rat hearts contain approximately 30% CFs, 64% CMs, and 6% ECs [Banerjee et al., 2007].”
BackgroundMethodSelf-citationEckes, J., Schmah, O., Siebers, J. W., Groh, U., Zschiedrich, S., Rautenberg, B., Hasenburg, A., Jansen, M., Hug, M. J., Winkler, K., et al. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-337 · Cited by 35
THE PERSISTENCE OF ADRIAMYCIN IN MAN AND RAT
Wilkinson, P. M., & Mawer, G. E. (1974) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1974.tb00244.x · Cited by 34 · cited 1×
“We also demonstrated how VCSs are good models for the study of other fibrotic stimuli besides TGFβ1, such as DOX (at concentrations within the therapeutic range) [Wilkinson and Mawer, 1974, Eckes et al., 2011] ( Fig.”
Background
Cited by
Basic Mechanisms of Diabetic Heart Disease
Ritchie, R. H., & Abel, E. D. (2020) · Circulation Research · doi:10.1161/circresaha.120.315913 · Cited by 708
Engineered materials for organoid systems
Kratochvil, M. J., Seymour, A. J., Li, T. L., Paşca, S. P., Kuo, C. J., & Heilshorn, S. C. (2019) · Nature Reviews Materials · doi:10.1038/s41578-019-0129-9 · Cited by 414
Cardiovascular disease models: A game changing paradigm in drug discovery and screening
Savoji, H., Mohammadi, M. H., Rafatian, N., Toroghi, M. K., Wang, E. Y., Zhao, Y., Korolj, A., Ahadian, S., & Radisic, M. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2018.09.036 · Cited by 223
3D Cardiac Cell Culture: A Critical Review of Current Technologies and Applications
Zuppinger, C. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00087 · Cited by 171
Archer, C. R., Sargeant, R., Basak, J., Pilling, J., Barnes, J. R., & Pointon, A. (2018) · Scientific Reports · doi:10.1038/s41598-018-28393-y · Cited by 126
Metadata
- Authors
- Figtree, G. A., Bubb, K. J., Tang, O., Kizana, E., & Gentile, C.
- Affiliations
- The University of Sydney (AU)
- Venue
- Cells Tissues Organs
- Publisher
- S. Karger AG
- Published
- 2017
- Volume
- 204
- Issue
- 3-4
- Pages
- 191-198
- ISSN
- 1422-6405 (ISSN-L)
- 1422-6421
- OpenAlex
- W2744628121
- Cited by
- 79
- References
- 38
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 9 · 2023: 6 · 2022: 9 · 2021: 14 · 2020: 13 · 2019: 6 · 2018: 5 · 2017: 1
- FWCI
- 5.28
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.karger.com/Services/SiteLicenses (vor)
- www.karger.com/Services/SiteLicenses (tdm)
- Locations
- Cells Tissues Organs (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Heart Research Australia
- Heart Research Institute
- University of Sydney
- National Institutes of Health
- National Health and Medical Research Council
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, hanging drop culture, cardiomyocytes, endothelial cells, fibroblasts, TGF-β1, collagen deposition, doxorubicin cardiotoxicity, apoptosis, connective tissue growth factor, fibronectin
- MeSH terms
- Animals, Extracellular Matrix, Fibrosis, Humans, Apoptosis, Imaging, Three-Dimensional, Myocytes, Cardiac, Endothelial Cells, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.